InspireMD Inc.
NSPR | NASDAQ
$0.76
+$0.01 (+1.33%)
Sep 22, 2026, 1:46 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 8.98M | 7.01M | 6.21M | 5.17M | 4.5M | 2.49M |
Cost of Revenue | 6.33M | 5.5M | 4.4M | 4.05M | 3.74M | 2.4M |
Gross Profit | 2.65M | 1.51M | 1.81M | 1.12M | 754K | 83K |
Operating Income | -49.11M | -33.5M | -21.14M | -18.71M | -14.72M | -10.38M |
Interest Income | n/a | 1.56M | 1.29M | 250K | n/a | n/a |
Pretax Income | -48.72M | -31.95M | -19.85M | -18.46M | -14.87M | -10.54M |
Net Income | -48.79M | -32.01M | -19.92M | -18.49M | -14.92M | -10.54M |
Selling & General & Admin | 37.26M | 21.38M | 14.97M | 12.02M | 10.31M | 8.23M |
Research & Development | 15M | 13.63M | 7.98M | 7.81M | 5.16M | 2.23M |
Other Expenses | -502K | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 51.76M | 35.01M | 22.95M | 19.83M | 15.47M | 10.46M |
Interest Expense | n/a | n/a | n/a | n/a | 157K | 160K |
Selling & Marketing Expenses | 16.55M | 6.07M | 3.87M | 3.66M | 2.91M | 2.1M |
Cost & Expenses | 58.09M | 40.51M | 27.35M | 23.88M | 19.21M | 12.87M |
Income Tax Expense | 63K | 59K | 65K | 28K | 45K | 4K |
Shares Outstanding (Basic) | 73.47M | 41.93M | 24.27M | 7.87M | 7.35M | 1.51M |
Shares Outstanding (Diluted) | 73.47M | 41.93M | 24.27M | 7.87M | 7.35M | 1.51M |
EPS (Basic) | -0.76 | -0.76 | -0.82 | -2.35 | -2.03 | -6.90 |
EPS (Diluted) | -0.76 | -0.76 | -0.82 | -2.35 | -2.03 | -6.90 |
EBITDA | -48.25M | -31.67M | -19.62M | -18.28M | -14.56M | -10.23M |
EBIT | -48.72M | -31.95M | -19.85M | -18.46M | -14.72M | -10.38M |
Depreciation & Amortization | 476K | 280K | 232K | 188K | 161K | 151K |
Add to Watchlist
Select watchlists to add or remove NSPR